Prostate cancer remains one of the most common cancer diagnoses among men in North America. The majority are treated with surgery or radiotherapy; and the advent of technological precision has driven remarkable improvements in clinical outcomes. Here, we highlight existing controversies surrounding the use of radiotherapy in the management of prostate cancer, with specific focus on different clinical scenarios.
|Title of host publication
|Number of pages
|E-pub ahead of print - Feb 21 2017
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging